Market Newsdesk

~ Expands
Depth of
Senior Leadership Team ~

LA JOLLA, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”), today announced that Angela Grant has been appointed Chief Legal Officer, effective immediately. Ms. Grant has over 30 years of operational and legal experience in the insurance industry and will oversee all in-house and corporate counsel duties. Ms. Grant will also play a prominent role in regulatory, compliance and strategic matters.

“Angela brings tremendous experience and insight to Palomar’s executive leadership group,” commented Mac Armstrong, Chairman and Chief Executive Officer. “As we expand our team, I am impressed not only by Angela’s impeccable legal credentials, but by her wide-ranging insurance experience. Her approach to ethics and compliance, as well as business development, make her an excellent cultural fit at Palomar, and she will be an invaluable asset to our Company in the years to come.”

“I am excited to bring my experience and passion to Palomar in the Chief Legal Officer role,” said Ms. Grant. “The people at Palomar are an ethical, agile team devoted to supporting their fellow employees and customers. I am proud to play a role in Palomar’s strategic mission and look forward to instituting solutions that further drive profitable growth.”

Ms. Grant most recently served as Chief Legal & Innovation Officer at CSE Insurance Group. Previously, Ms. Grant served as the Head of Compliance & Legal at Hippo Insurance. In addition to her legal and compliance background, past leadership roles at Esurance, Kemper and GEICO burnished her credentials in mergers and acquisitions, corporate governance, and strategy. Ms. Grant received her juris doctor from the Texas A&M University School of Law and holds a bachelor’s degree in Business Administration from the University of North Texas. She is a member of the State Bar of Texas, State Bar of California (Registered In-House Counsel), American Bar Association, Society of Corporate Compliance and Ethics, Association of Insurance Compliance Professionals (AICP), and the National Association of Women Lawyers (NAWL).

About Palomar Holdings, Inc.

Palomar Holdings, Inc. is the holding company of subsidiaries Palomar Specialty Insurance Company, Palomar Specialty Reinsurance Company Bermuda Ltd., Palomar Insurance Agency, Inc. and Palomar Excess and Surplus Insurance Company. Palomar is an innovative insurer that focuses on the provision of specialty property insurance for residential and commercial clients. Palomar’s underwriting and analytical expertise allow it to concentrate on certain markets that it believes are underserved by other insurance companies, such as the markets for earthquake, wind and flood insurance. Palomar’s principal insurance subsidiary, Palomar Specialty Insurance Company, is an admitted carrier in 31 states and has an A.M. Best financial strength rating of “A-” (Excellent).

Investor Relations

1-619-771-1743
[email protected]

VANCOUVER, British Columbia and SEATTLE, Nov. 30, 2020 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved a new employment inducement grant of stock options to purchase a total of 147,477 shares of common stock with a grant date of November 30, 2020 (the “Inducement Grant”) for Eric Bjerkholt, the Company’s chief financial officer.

The stock options approved under the Inducement Grant were issued on terms substantially similar to Chinook’s 2015 Equity Incentive Plan and have an exercise price per share equal to $13.98, the closing price per share of Chinook’s common stock on the grant date. The stock options vest over four years, with 25% vesting on November 16, 2021 and 1/36^th of the remaining shares vesting monthly thereafter, subject to Mr. Bjerkholt’s continued employment on each such date. The stock options have a 10-year term and are subject to the terms and conditions of the stock option agreement.

The Company granted the stock options as a material inducement to Mr. Bjerkholt for entering into employment with Chinook Therapeutics, Inc. in accordance with Nasdaq listing Rule 5635(c)(4).

About Chinook Therapeutics
, Inc.

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare, severe chronic kidney disorders with opportunities for well-defined clinical pathways. Chinook’s lead program is atrasentan, an investigational Phase 3-ready endothelin receptor antagonist for the treatment of IgA nephropathy and other primary glomerular diseases. BION-1301, an investigational anti-APRIL monoclonal antibody is being evaluated in a Phase 1b trial for IgA nephropathy. In addition, Chinook is advancing CHK-336, a small-molecule preclinical development candidate for the treatment of primary hyperoxaluria, as well as research programs for other rare, severe chronic kidney diseases, including polycystic kidney disease. Chinook is building its pipeline by leveraging insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with differentiating mechanisms of action against key kidney disease pathways. To learn more, visit www.chinooktx.com.

Contact:

Noopur Liffick
Vice President, Investor Relations & Corporate Communications
510-809-2465
[email protected]
[email protected]

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) is pleased to announce that it has completed the US$100 million at-the-market equity offering (the “ATM Program”) announced on October 20, 2020. In connection with the ATM Program, the Company issued a total of 9,266,587 common shares from treasury for gross proceeds of approximately US$100 million.

Total net proceeds from the ATM Program will be used for working capital and general corporate purposes.

“We are very pleased with the outcome of the ATM Program,” said Jon Evans, President and CEO. “With over US$145 million in cash on our balance sheet, the Company is in a strong position to complete construction at Caucharí-Olaroz and advance strategic discussions to finance Thacker Pass.”

About Lithium Americas
:

Lithium Americas is a development-stage company with projects in Jujuy, Argentina and Nevada, USA.  The Company trades on both the Toronto Stock Exchange and on the New York Stock Exchange, under the ticker symbol “LAC”.

For further information contact:
Lithium Americas Corp.
Investor Relations
Suite 300 – 900 West Hastings Street
Vancouver, BC, V6C 1E5
Telephone: 778-656-5820
Email: [email protected] Website: www.lithiumamericas.com

Forward-Looking Statements
:

This news release contains “forward-looking information” and “forward-looking statements” (which we refer to collectively as forward-looking information) under the provisions of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking information. Examples of forward-looking information in this news release include the anticipated use of proceeds from the ATM Program, the benefits from such use of proceeds, the expected costs and timing to complete construction of the Caucharí-Olaroz project, and the expected costs and timing to advance strategic discussion to finance the Thacker Pass project.

Forward-looking information is based upon a number of factors and assumptions that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements expressed or implied by such information. Such information reflects the Company’s current views with respect to future events and is necessarily based upon a number of assumptions that, while considered reasonable by the Company today, are inherently subject to significant uncertainties and contingencies. These assumptions include, among others, any anticipated use of proceeds from the ATM Program, lithium market conditions and pricing, the Company’s ability to fund, advance and develop the Caucharí-Olaroz project and the Thacker Pass project into production, including results therefrom and timing thereof, the impacts of COVID-19 globally and in the jurisdictions in which we operate, and on the availability and movement of personnel, supplies and equipment, timing of regulatory approvals and permits, and on third parties we are in a contractual relationship with regarding the preparation of the definitive feasibility study for the Thacker Pass project and with respect to construction activities at the Caucharí-Olaroz project, accuracy of mineral resources, including whether such mineral resources can ever be converted into reserves, reliability of technical data, accuracy of current budget and construction estimates, that pending patents will be approved, ability to achieve commercial production, general economic conditions, maintenance of a positive business relationship with existing project partners, timely responses from governmental agencies responsible for reviewing and considering the Company’s permitting activities, the Company position in a competitive environment, a stable and supportive legislative, regulatory and community environment, and general economic and market conditions. Forward-looking information also involve risks, assumptions and other factors are set out in the Company’s management discussion analysis and most recent annual information form, copies of which are available on SEDAR at www.sedar.com.

Although the Company has attempted to identify important risks and assumptions, given the inherent uncertainties in such forward-looking information, there may be other factors that cause results to differ materially. Forward-looking information is made as of the date hereof and the Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. Accordingly, readers are cautioned not to place undue reliance on forward-looking information.

Converse, Indiana, Nov. 30, 2020 (GLOBE NEWSWIRE) — In the early stages of the COVID-19 response, First Farmers Bank & Trust launched a community program throughout its 36-location branch footprint to provide sustained support to organizations at risk from a funding standpoint. The Growing Good program featured three distinct elements aimed to connect and strengthen existing support networks and provided monetary support to organizations and individuals in need. Direct funding commitments to community foundations throughout Indiana and Illinois resulted in over $85,000 in donations to feed families in need and other considerations. Through the “Pigs to People to Pork” initiative, the organization was able to partner with pork producers, local processors, and Hoosiers Feeding the Hungry to provide over 20,000 pounds of frozen ground pork protein to food banks and rescue missions in both states. Finally, the “In this Together” initiative featured branch employee participation and contributions in all markets assisting EMS/first responders, police & fire departments, healthcare heroes, postal workers and humane shelter volunteers. In total through October, over $370,000 in direct assistance has been distributed to organizations placed in funding crises as a direct result of COVID-19.

“The board of directors and executive leadership team recognized that there would be an immediate funding impact to not-for-profit entities falling outside of federal program support. There was also immediate recognition of the supply chain disruption on protein distribution to food banks and direct meal assistance. We’re grateful that we could work directly with local entities to meet both the emergent needs and sustained challenges throughout the year. We’re still seeing new challenges come up in a variety of areas that are a result of massive changes to production and distribution processes. We’ll continue to look for more ways to help our communities because the overall impact is far from over.” -Tade J Powell, Sr. Vice President, Communications & Public Relations Director

First Farmers Financial Corp is a $2.1 billion financial holding company headquartered in Converse, Indiana. First Farmers Bank & Trust has offices throughout Carroll, Cass, Clay, Grant, Hamilton, Howard, Huntington, Madison, Marshall, Miami, Starke, Sullivan, Tippecanoe, Tipton, Vigo and Wabash counties in Indiana and offices in Coles, Edgar and Vermilion counties in Illinois. First Farmers Financial Corp is traded on the OTC Markets Group, Inc. “OTCQX” exchange under the ticker symbol: FFMR.

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. PERSONS.

LOS ANGELES and TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — The Tinley Beverage Company (CSE:TNY, OTC:TNYBF) (“Tinley’s”) is pleased to announce that it has entered into an agreement with Peak Processing Solutions, a Canadian subsidiary of Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH) (“Peak” and “Althea” respectively), to produce Tinley’s ’27 products in Canada. Tinley’s ’27 is the second family of cannabis-infused products that Tinley’s has contracted to launch in Canada, the other being the single-serve ready-to-drink sparkling elixirs now made in California as Tinley’s Tonics.

Peak’s equipment is uniquely configured to produce and pack in the 150 mL bottle format that Tinley’s will use for the Tinley’s ’27 drinks in Canada. The discrete, convenient container size permits easy use and mixing at home or at private functions with friends and colleagues. Under the Agreement, Peak holds exclusivity for the manufacture and distribution of these three Tinley’s products in Canada until Tinley’s meets certain minimum orders.

Late last year, Tinley’s won the coveted Gold and Silver awards in California’s Emerald Cup, the largest cannabis competition in the world. The products being produced by Peak include the Canadian version of award-winning Coconut Cask, a Caribbean coconut elixir. Other products include an Italian-inspired, almond, apricot and vanilla elixir and a cinnamon-barrel elixir. All contain a scientifically-advanced emulsion that enables consumers to enjoy an uplifting, broad-spectrum effect with rapid onset. The technology also enables consistent dosing, even dispersion of active material throughout the product, and shelf stability.

The source provider of this cannabis emulsion has completed production and testing of the batch that will be used in these products. Non-cannabis ingredients were shipped from Tinley’s California facility and certain local suppliers last week. Peak is therefore able to begin testing and other Health Canada-mandated preparatory work immediately. The products will be substantially the same in Canada as in California, with requisite packaging, labelling and dosing changes.

As previously disclosed, the Company’s sales agent, Great North Distributors, has begun initial conversations with certain provincial cannabis boards, and it believes there will be significant interest from at least two notable buyers. The Company is working diligently to make the products available throughout Canada.

The Tinley’s ’27 brand pays homage to the year 2727 BC, the earliest recorded use of medical cannabis.

“The Agreement with Tinley’s is yet another key milestone for Peak. We are very excited to be working with Tinley’s to manufacture and distribute their market leading products in Canada and we look forward to building a long-term relationship with them. The addition of the Tinley’s agreement to Peak’s growing list of contracts increases our 12 months expected revenue yet again,” said Josh Fegan, CEO of Althea.

“The Agreement with Peak is an exciting step for our company as we seek to further drive geographic expansion through launch of our second product family in the Canadian market. Peak’s facility and team of professionals deliver the world class standard of Cannabis 2.0 co-packing services that we strive to provide at our own licensed co-packing facility in Long Beach, California,” said Richard Gillis, President of Tinley California. “Peak’s team has already demonstrated expert capabilities with the depth and rigor required to produce our sophisticated formulations in a compliant and consistent manner. Our team is confident that they can support the growth and scalability we anticipate requiring to execute in Canada’s booming infused drink category in the months and years to come.”

About


The


Tinley Beverage Company


Inc.


and Beckett’s Tonics California

Beckett’s Tonics California, a subsidiary of The Tinley Beverage Company, created the Beckett’s Tonics™ and Beckett’s ’27™ line of liquor-inspired, terpene-infused, non-alcoholic beverages. Beckett’s™-branded products are available in mainstream food, beverage and specialty retailers, as well as on-premises locations, primarily in California. The cannabis-infused versions of these products are available under the Tinley’s™ Tonics and Tinley’s™ ’27 brands in licenced dispensaries and delivery services throughout California. The Company is working to launch the full product line in Canada. The Company has also built a 20,000 square foot cannabis beverage manufacturing facility in Long Beach, California.

About Althea Group Holdings Limited

Althea is an Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis and is listed publicly on the Australian Securities Exchange (ASX:AGH). Althea also offers a range of products, education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. Althea currently operates within highly regulated medicinal cannabis markets including Australia and the United Kingdom, with plans to expand into Germany, emerging markets throughout Asia and other parts of Europe. To learn more, please visit: www.althea.life

Forward-Looking Statements

This press release contains or refers to forward-looking information and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and the other risks involved in the mineral exploration and development industry. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

Products, formulations and timelines outlined herein are subject to change at any time.

For further information on The Tinley Beverage Company, including media inquiries, please contact:

The Tinley Beverage Company Inc.

[email protected]

Twitter: @drinktinleys and @drinkbecketts
Instagram: @drinktinleys and @drinkbecketts
www.drinktinley.com
www.drinkbecketts.com
OTC:TNYBF CSE:TNY

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/703190e0-92d2-40a9-afd1-22661559e9c3